- Report
- January 2024
- 190 Pages
Global
From €4759EUR$4,900USD£4,106GBP
- Report
- December 2023
- 157 Pages
Global
€4851EUR$4,995USD£4,185GBP
- Report
- January 2022
- 60 Pages
Global
From €1457EUR$1,500USD£1,257GBP
- Drug Pipelines
- November 2019
- 75 Pages
Global
From €1943EUR$2,000USD£1,676GBP
The Fracture Drug market is a subset of the Musculoskeletal Disorders Drugs market, which focuses on treatments for conditions such as osteoporosis, arthritis, and other bone and joint diseases. Fracture Drugs are used to treat bone fractures, which can be caused by trauma, disease, or other medical conditions. These drugs are used to reduce pain, promote healing, and prevent further damage. Commonly used Fracture Drugs include bisphosphonates, calcitonin, and teriparatide. Bisphosphonates are used to reduce bone loss and increase bone density, while calcitonin is used to reduce pain and inflammation. Teriparatide is used to stimulate new bone growth.
Some companies in the Fracture Drug market include Amgen, Eli Lilly, Merck, and Novartis. Show Less Read more